Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies
NCT07240974
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory B-cell Malignancies
Interventions
DRUG:
ZZSW-01 injection
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology